# A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis

> **NCT00242853** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 48 (—)

## Conditions studied

- Rheumatoid Arthritis
- Osteoarthritis

## Interventions

- **PROCEDURE:** Power doppler ultrasonography
- **PROCEDURE:** High frequency ultrasonography
- **PROCEDURE:** Exhaled nitric oxide assessment

## Key facts

- **NCT ID:** NCT00242853
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 48 (—)
- **Last updated:** 2008-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00242853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00242853, "A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00242853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*